Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma

NCT00052624 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Xenova Biomedix